Results 11 to 20 of about 67,978 (217)
Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa. [PDF]
Cryptococcal meningitis (CM) remains a leading cause of death for HIV-infected individuals in sub-Saharan Africa. Improved treatment strategies are needed if individuals are to benefit from the increasing availability of antiretroviral therapy.
Josephine V J Lightowler +5 more
doaj +3 more sources
Cryptococcal meningitis occurred in an elderly Coloured woman in the Northern Cape. She presented with symptoms and signs suggestive of encephalitis 4 weeks after a cholecystectomy. After the administration of cortisone, cryptococcal organisms were isolated in her cerebrospinal fluid.
van den Ende, E.W. +2 more
core +6 more sources
Cryptococcal meningitis in India
Cryptococcal meningitis caused by the environmental yeast Cryptococcus neoformans has emerged as a significant pathogen in immunocompromised and immunocompetent patient especially in human immunodeficiency virus (HIV) or acquired immune deficiency ...
Pushpa Yadav +3 more
doaj +2 more sources
Objective To summarize the clinical manifestations and diagnostic and therapeutic strategies of 102 cases with cryptococcal meningitis and/or cryptococcal meningoencephalitis, and to improve the diagnosis and treatment of cryptococcal meningitis ...
Yan-yu CHANG, Xue-qiang HU
doaj +1 more source
Immunocompromised patients are at increased risk of disseminated cryptococcal infection, often presenting as a primary respiratory infection with yeast cells originating from bird excreta. Because Cryptococcus neoformans has a tropism for cerebrospinal fluid, most patients suffer from meningitis or meningoencephalitis.
Spil, W.E. van +5 more
openaire +3 more sources
Cryptococcal meningitis is a common opportunistic infection in AIDS patients, particularly in Southeast Asia and Africa. Cases also occur in patients with other forms of immunosupression and in apparently immunocompetent individuals. Mortality from HIV-associated cryptococcal meningitis remains high (10-30%), even in developed countries, because of the
Tihana, Bicanic, Thomas S, Harrison
+7 more sources
Pulmonary Cryptococcosis in Apparently Immunocompetent Hosts: Host Susceptibility, Occult Immunodeficiency and Clinical Implications. [PDF]
ABSTRACT Pulmonary cryptococcosis (PC) in apparently immunocompetent hosts—now the majority of non‐HIV cases in Asia—cannot be explained by the traditional opportunistic infection paradigm. Three epidemiological observations point toward occult immune susceptibility: familial clustering documented in multiple case reports and small family studies ...
Ma R, Yang X.
europepmc +2 more sources
Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days. [PDF]
Cryptococcal meningoencephalitis is an urgent global health problem. Induction regimens using 14 days of amphotericin B deoxycholate (dAmB) are considered the standard of care but may not be suitable for resource-poor settings.
Sharp, Andrew D +38 more
core +1 more source
Shunting in cryptococcal meningitis [PDF]
OBJECT Patients with cryptococcal meningitis often develop symptomatic intracranial hypertension. The need for permanent CSF diversion in these cases remains unclear. METHODS Cases of cryptococcal meningitis over a 5-year period were reviewed from a single, large teaching hospital.
Jacob, Cherian +2 more
openaire +2 more sources
A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in Blantyre, Malawi. [PDF]
OBJECTIVE: We have previously reported high ten-week mortality from cryptococcal meningitis in Malawian adults following treatment-induction with 800 mg oral fluconazole (57% [33/58]).
Allain, TJ +53 more
core +1 more source

